Sign in

CIK 0001706431

  • Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812730369
Phone
+1 415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 4 Open-market sale 10% owner sold 287,736 shares at an average $27.31 ($7,856,738)
  2. 4 Open-market sale 10% owner sold 182,083 shares at an average $27.26 ($4,964,081)
  3. 4 Open-market sale Director sold 17,915 shares at $27.38 ($490,549)
  4. 4 Open-market sale Director sold 17,915 shares at $20.67 ($370,278)
  5. 4 Open-market sale Director sold 17,915 shares at $21.90 ($392,335)
  6. 4 Other disposition Director disposed of 1,000,000 shares (other)
  7. 4 Other disposition 10% owner disposed of 1,000,000 shares (other)
  8. 4 Other disposition Director disposed of 1,000,000 shares (other)
  9. 4 Other disposition 10% owner disposed of 1,000,000 shares (other)
  10. 4 Other disposition Director disposed of 1,000,000 shares (other)
  11. 4 Other disposition 10% owner disposed of 1,000,000 shares (other)
  12. 4 Other disposition Director disposed of 500,000 shares (other)
  13. 4 Other disposition 10% owner disposed of 500,000 shares (other)
  14. 4 Open-market sale 10% owner sold 130,364 shares at an average $27.97 ($3,645,758)
  15. 4 Other disposition Director disposed of 1,500,000 shares (other)
  16. 4 Other disposition 10% owner disposed of 1,500,000 shares (other)
  17. 4 Exercise or conversion EVP, Research & CSO acquired 78,093 shares (option exercise)
  18. 4 Open-market sale Director sold 17,915 shares at $30.29 ($542,685)
  19. 4 Open-market sale Chief Medical Officer sold 5,000 shares at $30.00 ($150,000)
  20. 4 Open-market sale Director sold 5,000 shares at $30.00 ($150,000)

Page 11 of 25 · 491 filings